Waldron Private Wealth’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,000
Closed -$11 509
2024
Q2
$11 Hold
10,000
﹤0.01% 418
2024
Q1
$11 Buy
+10,000
New +$11 ﹤0.01% 432
2021
Q1
Sell
-10,700
Closed -$5K 315
2020
Q4
$5K Hold
10,700
﹤0.01% 293
2020
Q3
$5K Hold
10,700
﹤0.01% 276
2020
Q2
$7K Hold
10,700
﹤0.01% 258
2020
Q1
$9K Sell
10,700
-10,700
-50% -$15.3K ﹤0.01% 238
2019
Q4
$35K Hold
21,400
﹤0.01% 271
2019
Q3
$23K Hold
21,400
﹤0.01% 252
2019
Q2
$26K Hold
21,400
﹤0.01% 240
2019
Q1
$30K Hold
21,400
﹤0.01% 251
2018
Q4
$25K Buy
+21,400
New +$31.8K ﹤0.01% 212

Waldron Private Wealth's GEN Position: Q3 2024 in Review

Waldron Private Wealth sold out of Genesis Healthcare, Inc. (GEN) in Q3 2024, closing a stake of 10,000 shares — an estimated $11 sold.

Waldron Private Wealth first reported a position in GEN in Q4 2018 and held it in 11 quarters. The position peaked at $35K in Q4 2019. 1 fund tracked by Wall St. Rank holds GEN as of Q3 2024.

  • Waldron Private Wealth reported no remaining Genesis Healthcare, Inc. position as of Q3 2024 after selling out during the quarter.
  • Waldron Private Wealth sold 10,000 Genesis Healthcare, Inc. shares in Q3 2024, an estimated $11.
  • Waldron Private Wealth first reported a position in Genesis Healthcare, Inc. in Q4 2018 and held it in 11 quarters.
  • Waldron Private Wealth's Genesis Healthcare, Inc. position peaked at $35K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2024.

Based on Waldron Private Wealth's 13F filing for Q3 2024, filed 21 Oct 2024.